Literature DB >> 24293357

Prostate angiogenesis in development and inflammation.

Letitia Wong1, Jerry Gipp, Jason Carr, Christopher J Loftus, Molly Benck, Sanghee Lee, Vatsal Mehta, Chad M Vezina, Wade Bushman.   

Abstract

BACKGROUND: Prostatic inflammation is an important factor in development and progression of BPH/LUTS. This study was performed to characterize the normal development and vascular anatomy of the mouse prostate and then examine, for the first time, the effects of prostatic inflammation on the prostate vasculature.
METHODS: Adult mice were perfused with India ink to visualize the prostatic vascular anatomy. Immunostaining was performed on the E16.5 UGS and the P5, P20, and adult prostate to characterize vascular development. Uropathogenic E. coli 1677 was instilled transurethrally into adult male mice to induce prostate inflammation. RT-PCR and BrdU labeling was performed to assay anigogenic factor expression and endothelial proliferation, respectively.
RESULTS: An artery on the ventral surface of the bladder trifurcates near the bladder neck to supply the prostate lobes and seminal vesicle. Development of the prostatic vascular system is associated with endothelial proliferation and robust expression of pro-angiogenic factors Pecam1, Tie1, Tek, Angpt1, Angpt2, Fgf2, Vegfa, Vegfc, and Figf. Bacterial-induced prostatic inflammation induced endothelial cell proliferation and increased vascular density but surprisingly decreased pro-angiogenic factor expression.
CONCLUSIONS: The striking decrease in pro-angiogenic factor mRNA expression associated with endothelial proliferation and increased vascular density during inflammation suggests that endothelial response to injury is not a recapitulation of normal development and may be initiated and regulated by different regulatory mechanisms.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  development; inflammation; prostate; vasculature

Mesh:

Substances:

Year:  2013        PMID: 24293357      PMCID: PMC3901368          DOI: 10.1002/pros.22751

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  59 in total

Review 1.  Role of vascular endothelial growth factor in regulation of physiological angiogenesis.

Authors:  N Ferrara
Journal:  Am J Physiol Cell Physiol       Date:  2001-06       Impact factor: 4.249

2.  Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P.

Authors:  M L Kwan; A D Gómez; P Baluk; H Hashizume; D M McDonald
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-02       Impact factor: 5.464

3.  Relationship between benign prostatic hyperplasia and history of coronary artery disease in elderly men.

Authors:  K M Weisman; G E Larijani; M R Goldstein; M E Goldberg
Journal:  Pharmacotherapy       Date:  2000-04       Impact factor: 4.705

4.  Vascular anatomy of the rat ventral prostate.

Authors:  A Shabsigh; N Tanji; V D'Agati; T Burchardt; M Burchardt; O Hayek; R Shabsigh; R Buttyan
Journal:  Anat Rec       Date:  1999-12-01

5.  Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate.

Authors:  J A Doll; F K Reiher; S E Crawford; M R Pins; S C Campbell; N P Bouck
Journal:  Prostate       Date:  2001-12-01       Impact factor: 4.104

6.  Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation.

Authors:  T Ezaki; P Baluk; G Thurston; A La Barbara; C Woo; D M McDonald
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

7.  Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Authors:  M C Michel; L Mehlburger; H Schumacher; H U Bressel; M Goepel
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

8.  Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

Authors:  J B Meigs; B Mohr; M J Barry; M M Collins; J B McKinlay
Journal:  J Clin Epidemiol       Date:  2001-09       Impact factor: 6.437

9.  Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction.

Authors:  Andreas P Berger; Martina Deibl; Nicolai Leonhartsberger; Jasmin Bektic; Wolfgang Horninger; Gernot Fritsche; Hannes Steiner; Alexandre E Pelzer; Georg Bartsch; Ferdinand Frauscher
Journal:  BJU Int       Date:  2005-11       Impact factor: 5.588

10.  Chronic ischemia alters prostate structure and reactivity in rabbits.

Authors:  R Kozlowski; R T Kershen; M B Siroky; R J Krane; K M Azadzoi
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

View more
  5 in total

1.  Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.

Authors:  Rajagopal N Aravalli; Neil C Talbot; Clifford J Steer
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

2.  Effect of preoperative finasteride on perioperative blood loss during transurethral resection of the prostate and on microvessel density in patients with benign prostatic hyperplasia: An open label randomized controlled trial.

Authors:  Uma Kant Dutt; Sunil Kumar; Lalgudi Narayanan Dorairajan; Bhawana Ashok Badhe; Ramanitharan Manikandan; Suresh Singh
Journal:  Urol Ann       Date:  2021-07-14

3.  Beta-3 adrenergic receptors could be significant factors for overactive bladder-related symptoms.

Authors:  Fukashi Yamamichi; Katsumi Shigemura; Hosny M Behnsawy; Masuo Yamashita; Toshiro Shirakawa; Masato Fujisawa
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Transcriptome analysis of cattle muscle identifies potential markers for skeletal muscle growth rate and major cell types.

Authors:  Bing Guo; Paul L Greenwood; Linda M Cafe; Guanghong Zhou; Wangang Zhang; Brian P Dalrymple
Journal:  BMC Genomics       Date:  2015-03-13       Impact factor: 3.969

5.  Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer.

Authors:  Ali Flores-Pérez; Laurence A Marchat; Sergio Rodríguez-Cuevas; Verónica Bautista-Piña; Alfredo Hidalgo-Miranda; Elena Aréchaga Ocampo; Mónica Sierra Martínez; Carlos Palma-Flores; Miguel A Fonseca-Sánchez; Horacio Astudillo-de la Vega; Erika Ruíz-García; Juan Antonio González-Barrios; Carlos Pérez-Plasencia; María L Streber; César López-Camarillo
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.